UCB SA (UCBJF)
PNK: UCBJF
· Real-Time Price · USD
150.70
0.00 (0.00%)
At close: May 02, 2025, 8:00 PM
0.00% (1D)
Bid | 150.7 |
Market Cap | 28.64B |
Revenue (ttm) | 5.45B |
Net Income (ttm) | 240M |
EPS (ttm) | 6.21 |
PE Ratio (ttm) | 24.27 |
Forward PE | n/a |
Analyst | n/a |
Ask | 150.7 |
Volume | 100 |
Avg. Volume (20D) | 350 |
Open | 150.70 |
Previous Close | 150.70 |
Day's Range | 150.70 - 150.70 |
52-Week Range | 131.15 - 209.66 |
Beta | 0.33 |
About UCBJF
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkin...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 26, 2008
Employees 9,052
Stock Exchange PNK
Ticker Symbol UCBJF
Website https://www.ucb.com

2 weeks ago · seekingalpha.com
United Community Banks, Inc. (UCB) Q1 2025 Earnings Call TranscriptUnited Community Banks, Inc. (NYSE:UCB ) Q1 2025 Earnings Conference Call April 22, 2025 9:00 AM ET Company Participants Lynn Harton - Chairman and CEO Jefferson Harralson - CFO Rob Edwards - CRO Rich...